首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children have caught the eye of Congress an
Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children have caught the eye of Congress an
admin
2014-09-17
31
问题
Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children have caught the eye of Congress and the New York state attorney general. Now they’re becoming the catalyst for calls to reform the way clinical trials of all drugs are reported.
Pressure is already causing some changes within the pharmaceutical industry. And it has put the US Food and Drug Administration (FDA), which approves new drugs, in the hot seat. If reforms are carried out, they could bring an unprecedented level of transparency to drug research.
The solution now under consideration: a public database, or registry, of drug trials, where companies would post the results of those trials.
In congressional testimony Thursday, a spokesman for the American Medical Association endorsed the registry and said it should include information on each trial’s purpose and objective, its design, and the dates it begins and ends. If the trial is not completed, the registry should include an explanation.
While drug companies have been eager to make public any positive results of their trials, recent revelations suggest they’ve balked at divulging tests when the results are not what they’d hoped to see. The furor has centered around the use of anti- depressants on children.
The industry has begun to make some moves to address the concerns about drug trials. Drug companies have agreed to set up a voluntary system of posting their drug trials on the Internet. But that seems unlikely to satisfy some members of Congress, who are expected to ! ntroduce legislation to establish a mandatory drug registry.
Last week, editors of a dozen influential medical journals announced that they would begin requiring drug companies to post a drug trial in a public database prior to accepting an article about it. Doctors rely on these articles to make treatment choices. The editors hope that the registry will force unfavorable drug studies, before kept secret, into the open.
Medical journals already had been tightening up on the authorship of their articles, insisting that authors declare if they had any conflicts of interest, such as any financial or other ties to the drug company, says Daniel Callahan, a director at the Hastings Center, a nonprofit bioethics research institute in Garrison, N.Y.
Information from previously undisclosed clinical trials could lower prices, reduce the number of badly designed trials, and help doctors considering the use of a drug for a non-approved purpose to know why it hash’ t been approved for that use.
Antidepressant drugs "have some serious side effects ... that seem to be much more common than people realize.., much more common than you might think from seeing drug ads and from reports on drug studies," says Joel Gurin, executive vice president of Consumer Reports. His magazine just finished a survey of readers showing a "dramatic shift from talk therapy to drug therapy for mental health problems" during the
past decade. In 1995, less than half of people getting mental health treatment —40 percent- got drug therapy. Today 68 percent receive drug treatment, Mr. Gurin says.
Some studies coming to light show that antidepressants work no better than placebos. Even better than merely registering drug trials, Caplan (director of the Center for Bioethics at the University of Pennsylvania in Philadelphia) suggests, would be to require that a new drug not only be "safe and do what it’ s sup- posed to do", but that it do it as well or better than other drugs already on the market. That, he says, would help push research into new areas and save money.
What is Caplan’s opinion in the last paragraph?
选项
A、Registry of drug trials is of no use.
B、We should make demands on new drugs besides registering drug trials.
C、To put requirements on new drugs is much more effective than registering drug trials.
D、A new drug must be safe and better than any other drugs already on the market.
答案
B
解析
最后一段中Caplan的观点是什么? Caplan指出“Even better than merely registering…”,“merely”这个词暗示,说话者意思是不仅要登记药品临床试验结果还要保证新药品安全并至少和市场上现有的药品一样有效。
转载请注明原文地址:https://kaotiyun.com/show/eTdO777K
0
专业英语八级
相关试题推荐
Howmanysinglegrandparentsaretakingcareoftheirgrandchildrenin2008?
WhichofthefollowingisTRUEaboutthesafetyofputtingphotosonline?
Chinesepeoplearenolongerstrangerstofood-safetycrisis—thecontaminatedvinegar,themeatthatglowedinthedark,theexp
ImprovingthebalancebetweentheworkingpartofthedayandtherestofitisagoalofagrowingnumberofworkersinrichWe
ImprovingthebalancebetweentheworkingpartofthedayandtherestofitisagoalofagrowingnumberofworkersinrichWe
TheNationalPeople’sCongressaimedtodoallthefollowingEXCEPT
随机试题
患者,女,77岁。突发剧烈头痛、恶心、呕吐6小时。体检:血压190/110mmHg,口角右偏,左侧鼻唇沟变浅,伸舌左偏,左侧偏瘫。问题1:病变部位可能是
真武汤主治二妙散主治
瘀血的病症特点,哪种说法不准确
外科病人最易发生水和钠代谢紊乱是
根据《中华人民共和国商业银行法》的规定,商业银行破产清算时的财产分配适用下列哪一种顺序?
基金托管人召集基金份额持有人大会,必须披露的事项不包括()。
某工业企业大量生产甲、乙两种产品。该企业采用品种法计算产品成本,适用的增值税税率为13%。2018年5月份,该企业发生的有关经济业务如下:(1)5月份开始生产甲、乙产品,当月投产甲产品270件,耗用材料4800千克;投产乙产品216件,耗用材料
让一个吸烟上瘾的人扮演因吸烟患肺癌而接受治疗的病人,之后他戒了烟。这一情景中对戒烟起作用的主要因素是()
已知三位青年小刘、小陈、小李的年龄各不相同。有人问到年龄时他们分别回答如下:(1)小刘说:“我22岁,比小陈小2岁,比小李大1岁一”(2)小陈说:“我不是年龄最小的,小李比我小3岁,小李是25岁。”(3)小李说:“我比小刘年龄小,小刘23岁,小陈比小
路由器转发分组上根据报文分组的
最新回复
(
0
)